Bronchoalveolar Fluid and Plasma Inflammatory Biomarkers in Contemporary ARDS Patients

PURPOSE: Bronchoalveolar fluid (BALF) and plasma biomarkers are often endpoints in early phase randomized trials (RCTs) in acute respiratory distress syndrome (ARDS). With ARDS mortality decreasing, we analyzed baseline biomarkers in samples from contemporary ARDS patients participating in a prior R...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biomarkers
Main Authors: Stapleton, Renee D., Suratt, Benjamin T., Neff, Margaret J., Wurfel, Mark M., Ware, Lorraine B., Ruzinski, John T., Caldwell, Ellen, Hallstrand, Teal S., Parsons, Polly E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7147943/
https://ncbi.nlm.nih.gov/pubmed/30744430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/1354750X.2019.1581840
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados